Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTMTA.L Regulatory News (TMTA)

  • There is currently no data for TMTA

Directorate Change

26 Sep 2023 07:00

RNS Number : 5937N
TMT Acquisition PLC
26 September 2023
 

 

TMT Acquisition plc

("TMT Acquisition" or the "Company")

Directorate Change

TMT Acquisition (LSE: TMTA), the investment business established to pursue opportunities in the technology, media and telecom sector, is pleased to announce that Paul Tuson will join the Board of TMT Acquisition as a Non-Executive Director with immediate effect.

Paul qualified as a chartered accountant at KPMG, with over twenty years' post-qualification experience, he has served as Chief Financial Officer as well as Non-Executive Director on a number of AIM quoted companies in the media and technology industries. Over this period, he has led successful IPOs, fundraisings and venture capital exits.

Paul served as a Non-Executive Director of AIM quoted financial services company, Harwood Wealth Management Group plc, from March 2016 to April 2020 when it was acquired by Hurst Point Group, now Argentis Group Limited. He was Finance Director and then Chief Financial Officer of Proton Partners International Limited (now Rutherford Health plc), the group committed to providing innovative cancer care to patients and led its IPO on NEX Exchange (now Aquis Exchange) in February 2019. Paul resigned from the Board of Rutherford Health plc in August 2019.

Harry Hyman, Non-Executive Chairman of TMT Acquisition, commented: "It is a pleasure to welcome Paul to the Board of TMT Acquisition. Paul brings with him a wealth of experience from his time spent in both the public and private spheres; he will be a fantastic addition to the Board."

No further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

For further information please contact:

TMT Acquisition plc

Harry Hyman

 

via focusIR

Dowgate Capital Limited - Financial Adviser and Broker

Nicholas Chambers

 

+44 (0)20 3903 7715

focusIR - Investor Relations

Kat Perez

kat.perez@focusir.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGZLRKFGFZM
Date   Source Headline
4th Mar 20247:00 amRNSAcceptances level
26th Feb 20247:00 amRNSAcceptances level
22nd Feb 20243:00 pmRNSAcceptances level, issue of equity & AIM Admission
19th Feb 20247:00 amRNSAcceptances level & offer closing
15th Feb 20243:51 pmRNSAcceptances level, issue of equity & AIM Admission
15th Feb 20247:00 amRNSBoard changes
13th Feb 20247:00 amRNSAcceptances Level
9th Feb 20248:16 amRNSOffer becomes wholly unconditional
8th Feb 20243:31 pmRNSAcceptances level, issue of equity & AIM Admission
7th Feb 20244:20 pmRNSOffer Unconditional (subject to AIM Admission)
7th Feb 202411:13 amRNSForm 8.3 - Belluscura Plc
5th Feb 20241:30 pmRNSResult of General Meeting
5th Feb 20247:00 amRNSAcceptances received in respect of the Offer
2nd Feb 202411:24 amRNSForm 8 (OPD) Belluscura plc
2nd Feb 202411:18 amRNSForm 8 (OPD) TMT Acquisition plc
1st Feb 20246:16 pmRNSForm 8 (OPD) TMT Acquisition plc - Amended
1st Feb 20246:14 pmRNSForm 8 (OPD) Belluscura plc - Amended
29th Jan 202411:42 amRNSForm 8.3 - Belluscura PLC
24th Jan 20246:24 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20246:17 pmRNSForm 8.3 - Belluscura
24th Jan 20246:02 pmRNSForm 8.3 - Belluscura PLC - Replacement
24th Jan 20245:49 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20243:25 pmRNSForm 8.3 - Belluscura plc
23rd Jan 20246:06 pmRNSForm 8.3 - Belluscura plc
19th Jan 20241:30 pmRNSPosting of Offer Document and Circular
22nd Dec 202312:10 pmRNSExtension to deadline for posting Offer Document
19th Dec 20237:00 amRNSInterim Results
28th Nov 20235:00 pmRNSExtension to deadline for posting Offer Document
9th Nov 20234:03 pmRNSHolding(s) in Company
9th Nov 202311:04 amRNSForm 8.3 - TMT Acquisition PLC
8th Nov 20235:52 pmRNSForm 8.3 - TMT Acquisition plc
8th Nov 202311:44 amRNSForm 8.3 - Belluscura PLC
7th Nov 20233:35 pmRNSForm 8.3 - TMT Acquisition PLC
2nd Nov 20236:15 pmRNSForm 8.3 - TMT Acquisition
2nd Nov 20234:22 pmPRNForm 8.3 - TMT Acquisitions Plc
2nd Nov 20234:20 pmPRNForm 8.3 - TMT Acquisitions Plc
1st Nov 20233:03 pmRNSReplacement: Rule 2.7 Announcement
31st Oct 20234:52 pmRNSRule 2.7 Announcement
26th Oct 202310:45 amRNSResult of AGM
25th Oct 20237:00 amRNSStatement regarding possible offer
24th Oct 20238:26 amRNSForm 8 (OPD) TMT (offeree) re TMT
24th Oct 20238:15 amRNSForm 8 (OPD) TMT (offeree) re Belluecura PLC
24th Oct 20237:00 amRNSForm 8 (OPD) Belluscura plc
24th Oct 20237:00 amRNSForm 8 (OPD) TMT Acquisition PLC
19th Oct 20234:09 pmRNSForm 8.3 - TMT Acquisition PLC
19th Oct 20234:02 pmRNSForm 8.3 - Belluscura PLC
18th Oct 20233:19 pmRNSForm 8.3 - Belluscura plc
18th Oct 20231:38 pmRNSForm 8.3 - Belluscura plc
18th Oct 202311:54 amRNSForm 8.3 - Belluscura plc
17th Oct 20233:22 pmRNSForm 8.3 - Belluscura plc - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.